Evidence map›Paper›PMID 38496439›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Coronary Microvascular Function Following Severe Preeclampsia.

Michael C Honigberg, Katherine E Economy, Maria A Pabón, Xiaowen Wang, Claire Castro, Jenifer M Brown, Sanjay Divakaran, Brittany N Weber, Leanne Barrett, Anna Perillo and 15 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 1 country.

Michael C HonigbergCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0001-8630-5021
Katherine E EconomyDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Maria A PabónDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Xiaowen WangDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Claire CastroCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Jenifer M BrownDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Sanjay DivakaranDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Brittany N WeberDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Leanne BarrettCardiovascular Imaging Program, Departments of Radiology and Medicine, and Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Anna PerilloCardiovascular Imaging Program, Departments of Radiology and Medicine, and Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Anina Y SunCardiovascular Imaging Program, Departments of Radiology and Medicine, and Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Tajmara AntoineCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Faranak FarrohiDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Brenda DocktorDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Emily S LauCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Doreen DeFaria YehCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Pradeep NatarajanCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0001-8402-7435
Amy A SarmaCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Robert M WeisbrodWhitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA.
Naomi M HamburgWhitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA.
Jennifer E HoDivision of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Jason D RohCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Malissa J WoodCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Nandita S ScottCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Marcelo F Di CarliDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Brigham and Women's Hospital · USHarvard University · USBoston University · USBroad Institute · USBeth Israel Deaconess Medical Center · US

Funding

Noninvasive Cardiovascular Imaging Research Training ProgramT32HL094301 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Marcelo F DI CARLI · 2010 to 2026
$7.8M
Clonal hematopoiesis in the Womens Health Initiative Memory StudyR01HL148565 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ALEXANDER P REINER, Eric A. Whitsel · 2019 to 2026
$5.9M
Clonal hematopoiesis in humans: determinants of development and progressionR01HL148050 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI BALLANTYNE, CHRISTIE MITCHELL, NATARAJAN, PRADEEP · 2019 to 2022
$5.9M
Whole genome sequences in individuals to comprehensively characterize the genetic mechanisms of dyslipidemiasR01HL142711 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Satoshi Koyama, Gina Marie Peloso · 2019 to 2026
$4.7M
Endothelial Cell Health Across the Spectrum of Cardiometabolic DiseaseR01HL168889 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Naomi Miriam Hamburg, Jennifer E Ho · 2023 to 2026
$3.1M
Mineralocorticoid receptor, coronary microvascular function, and cardiac efficiency in hypertensionR01HL162960 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Gail Kurr Adler, Marcelo F DI CARLI · 2023 to 2026
$3.1M
Integrating Artificial Intelligence for Optimal Analysis of CardiacPET/CTR01EB034586 · NIBIB · CEDARS-SINAI MEDICAL CENTER · PI DI CARLI, MARCELO F, SLOMKA, PIOTR J · 2022 to 2025
$2.9M
Long-Term Endothelial Effects of COVID-19 in ObesityR01HL160003 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HAMBURG, NAOMI MIRIAM, HO, JENNIFER E · 2022 to 2025
$2.8M
HFpEF Susceptibility in Women: The Role of InflammationK23HL159243 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Emily Lau · 2022 to 2026
$1.1M
Cardiac Perfusion, Structure, and Function across the Primary Aldosteronism SpectrumK23HL159279 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Jenifer Michelle Brown · 2022 to 2026
$1.0M
Advanced CV imaging and immunophenotyping to study coronary vascular health in psoriasisK23HL159276 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI WEBER, BRITTANY NICOLE · 2021 to 2025
$962k
Mentoring in Patient-Oriented and Translational HFpEF ResearchK24HL153669 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Jennifer E Ho · 2020 to 2026
$744k
NHLBI NIH HHS K08 HL166687NHLBI NIH HHS K23 HL159243NHLBI NIH HHS K23 HL159276NHLBI NIH HHS K23 HL159279NHLBI NIH HHS K24 HL153669NHLBI NIH HHS R01 HL142711NHLBI NIH HHS R01 HL148050NHLBI NIH HHS R01 HL148565NHLBI NIH HHS R01 HL160003NHLBI NIH HHS R01 HL162960NHLBI NIH HHS R01 HL168889NHLBI NIH HHS T32 HL094301NIBIB NIH HHS R01 EB034586
6 · The paper itself

Abstract

Background: Preeclampsia is a pregnancy-specific hypertensive disorder associated with an imbalance in circulating pro- and anti-angiogenic proteins. Preclinical evidence implicates microvascular dysfunction as a potential mediator of preeclampsia-associated cardiovascular risk. Methods: Women with singleton pregnancies complicated by severe antepartum-onset preeclampsia and a comparator group with normotensive deliveries underwent cardiac positron emission tomography (PET) within 4 weeks of delivery. A control group of pre-menopausal, non-postpartum women was also included. Myocardial flow reserve (MFR), myocardial blood flow (MBF), and coronary vascular resistance (CVR) were compared across groups. Soluble fms-like tyrosine kinase receptor-1 (sFlt-1) and placental growth factor (PlGF) were measured at imaging. Results: The primary cohort included 19 women with severe preeclampsia (imaged at a mean 16.0 days postpartum), 5 with normotensive pregnancy (mean 14.4 days postpartum), and 13 non-postpartum female controls. Preeclampsia was associated with lower MFR ( Conclusions: In this exploratory study, we observed reduced coronary microvascular function in the early postpartum period following severe preeclampsia, suggesting that systemic microvascular dysfunction in preeclampsia involves the coronary microcirculation. Further research is needed to establish interventions to mitigate risk of preeclampsia-associated cardiovascular disease.

Indexed as

cardiac positron emission tomographycoronary microvascular functionpreeclampsiapregnancywomen’s health

Identifiers

PMID38496439
PMCPMC10942503
OpenAlexW4392448228

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.